This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Q2 Boost for Tenet (THC): A Healthy Dose of Long-Term Gains
by Kaibalya Pravo Dey
Tenet (THC) shares jump 8.3% since Q2 earnings beat, as investors grow increasingly confident about the company's future prospects.
How to Find Strong Buy Medical Stocks Using the Zacks Rank
by Zacks Equity Research
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Zacks Rank.
Should JPMorgan Diversified Return U.S. Mid Cap Equity ETF (JPME) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for JPME
Zacks.com featured highlights Hilton Grand Vacations, Tenet Healthcare, Universal Health, Popular and B2Gold
by Zacks Equity Research
Hilton Grand Vacations, Tenet Healthcare, Universal Health, Popular and B2Gold have been highlighted in this Screen of The Week article.
Bet on These 5 Top-Ranked Value Stocks With Discounted PEG
by Urmimala Biswas
Invest in some top value stocks such as Hilton Grand Vacations (HGV), Tenet Healthcare (THC), Universal Health Services (UHS), Popular, Inc. (BPOP) and B2Gold Corp (BTG) that fit our screening criteria.
Should SPDR S&P 400 Mid Cap Value ETF (MDYV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for MDYV
What Makes Tenet Healthcare (THC) a Strong Momentum Stock: Buy Now?
by Zacks Equity Research
Does Tenet Healthcare (THC) have what it takes to be a top stock pick for momentum investors? Let's find out.
Are Investors Undervaluing Tenet Healthcare (THC) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
If You Invested $1000 in Tenet Healthcare a Decade Ago, This is How Much It'd Be Worth Now
by Zacks Equity Research
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Universal Health Services, Inc. (UHS) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Universal Health Services (UHS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Here's Why Tenet Healthcare (THC) is a Strong Momentum Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Tenet Healthcare Corporation (THC) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Tenet (THC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Despite Fast-paced Momentum, Tenet (THC) Is Still a Bargain Stock
by Zacks Equity Research
Tenet (THC) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Tenet (THC) Q2 Earnings Beat on Patient Volumes, '24 EPS View Up
by Zacks Equity Research
Tenet Healthcare's (THC) Q2 results reflect net revenue per case growth, higher pricing yield and a decline in overall expenses. It expects 2024 adjusted EPS within $10.41-$11.12, up from the previous guidance of $8.37-$9.41.
Tenet (THC) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for Tenet (THC) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Tenet Healthcare (THC) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Tenet (THC) delivered earnings and revenue surprises of 22.22% and 2.49%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Play Likely Earnings Beat With 5 Top-Ranked Stocks
by Sanghamitra Saha
Top-ranked stocks The Wingstop (WING), Amazon.com (AMZN), Burlington Stores (BURL), Tenet Healthcare (THC) and Twilio (TWLO) are likely to beat on the bottom line in their upcoming releases.
Tenet (THC) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
Tenet (THC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Best Momentum Stocks to Buy for July 23rd
by Zacks Equity Research
WGS, THC and APOG made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 23, 2024.
Can These 3 Hospital Stocks Beat Q2 Earnings Expectations?
by Kaibalya Pravo Dey
Rising patient volumes, admission and occupancy levels are expected to have benefited hospital players in the second quarter, partly offset by higher costs. THC, UHS and CYH will release earnings on Jul 24.
Here's How STERIS (STE) is Placed Ahead of Q1 Earnings
by Zacks Equity Research
STERIS' (STE) first-quarter fiscal 2025 results are likely to reflect the positives of the normalization of the Healthcare backlog, along with a core focus on pharma and MedTech.
Zacks.com featured highlights include Amazon.com, Halozyme Therapeutics, Tenet Healthcare and Atmos Energy
by Zacks Equity Research
Amazon.com, Halozyme Therapeutics, Tenet Healthcare and Atmos Energy are part of the Zacks Screen of the Week article.
New Strong Buy Stocks for July 23rd
by Zacks Equity Research
KRO, TEF, STX, WGS and THC have been added to the Zacks Rank #1 (Strong Buy) List on July 23, 2024.